Literature DB >> 87609

Warfarin enantiomers, anticoagulation, and experimental tumour metastasis.

A Poggi, L Mussoni, L Kornblihtt, E Ballabio, G de Gaetano, M B Donati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 87609     DOI： 10.1016/s0140-6736(78)90472-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Tissue procoagulant activity may be important in sustaining metastatic tumour growth.

Authors:  N J Carty; I Taylor; O S Roath; K el-Baruni; J L Francis
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

Review 3.  Inhibition of the arrest of hematogenously disseminated tumor cells.

Authors:  E Tsubura; T Yamashita; S Sone
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 4.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  Factor X-activating activity from Lewis lung carcinoma.

Authors:  P Hilgard; P Whur
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

6.  Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.

Authors:  P McCulloch; W D George
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

7.  Effects of anticoagulation and ileal resection on the development and spread of experimental intestinal carcinomas.

Authors:  R C Williamson; P J Lyndon; A J Tudway
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.